Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Vincent Calvez

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Wirden Marc; Simon Anne; Schneider Luminita; Tubiana Roland; Malet Isabelle; Ait-Mohand Hocine; Peytavin Gilles; Katlama Christine; Calvez Vincent; Marcelin Anne-Genevieve
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.
Mouscadet Jean-François; Arora Rohit; André Joseph; Lambry Jean-Christophe; Delelis Olivier; Malet Isabelle; Marcelin Anne-Geneviève; Calvez Vincent; Tchertanov Luba
HIV-1 IN alternative molecular recognition of DNA induced by raltegravir resistance mutations.
Soulié Cathia; Assoumou Lambert; Ghosn Jade; Duvivier Claudine; Peytavin Gilles; Ait-Arkoub Zaina; Molina Jean-Michel; Costagliola Dominique; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vincent Calvez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Wirden Marc; Simon Anne; Schneider Luminita; Tubiana Roland; Malet Isabelle; Ait-Mohand Hocine; Peytavin Gilles; Katlama Christine; Calvez Vincent; Marcelin Anne-Genevieve
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.
The Journal of antimicrobial chemotherapy 2009;64(5):1087-90.
2009: Mouscadet Jean-François; Arora Rohit; André Joseph; Lambry Jean-Christophe; Delelis Olivier; Malet Isabelle; Marcelin Anne-Geneviève; Calvez Vincent; Tchertanov Luba
HIV-1 IN alternative molecular recognition of DNA induced by raltegravir resistance mutations.
Journal of molecular recognition : JMR 2009;22(6):480-94.
2009: Soulié Cathia; Assoumou Lambert; Ghosn Jade; Duvivier Claudine; Peytavin Gilles; Ait-Arkoub Zaina; Molina Jean-Michel; Costagliola Dominique; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
AIDS (London, England) 2009;23(12):1605-8.
2009: Soulié Cathia; Tubiana Roland; Simon Anne; Lambert-Niclot Sidonie; Malet Isabelle; Canestri Ana; Brunet Christel; Murphy Robert; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):60-4.
2009: Wirden M; Tubiana R; Marguet F; Leroy I; Simon A; Bonmarchand M; Ait-Arkoub Z; Murphy R; Marcelin A G; Katlama C; Calvez V
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.
Journal of clinical microbiology 2009;47(5):1543-5.
2009: Malet Isabelle; Delelis Olivier; Soulie Cathia; Wirden Marc; Tchertanov Luba; Mottaz Philippe; Peytavin Gilles; Katlama Christine; Mouscadet Jean-François; Calvez Vincent; Marcelin Anne-Genevieve
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
The Journal of antimicrobial chemotherapy 2009;63(4):795-804.
2009: Descamps Diane; Lambert-Niclot Sidonie; Marcelin Anne-Geneviève; Peytavin Gilles; Roquebert Bénédicte; Katlama Christine; Yeni Patrick; Felices Mathieu; Calvez Vincent; Brun-Vézinet Françoise
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
The Journal of antimicrobial chemotherapy 2009;63(3):585-92.
2009: Delelis Olivier; Malet Isabelle; Na Li; Tchertanov Luba; Calvez Vincent; Marcelin Anne-Genevieve; Subra Frederic; Deprez Eric; Mouscadet Jean-François
The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation.
Nucleic acids research 2009;37(4):1193-201.
2009: Wirden Marc; Lambert-Niclot Sidonie; Marcelin Anne-Genevieve; Schneider Luminita; Ait-Mohand Hocine; Brunet Christel; Angleraud Francis; Amard Sylvain; Katlama Christine; Calvez Vincent
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
AIDS (London, England) 2009;23(1):95-9.
2009: Maïga Almoustapha-Issiaka; Malet Isabelle; Soulie Cathia; Derache Anne; Koita Victoria; Amellal Bahia; Tchertanov Luba; Delelis Olivier; Morand-Joubert Laurence; Mouscadet Jean-François; Murphy Robert; Cissé Mamadou; Katlama Christine; Calvez Vincent; Marcelin Anne-Genevieve
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.
Antiviral therapy 2009;14(1):123-9.
2008: Marcelin Anne-Geneviève; Flandre Philippe; Molina Jean-Michel; Katlama Christine; Yeni Patrick; Raffi Francois; Antoun Zeina; Ait-Khaled Mounir; Calvez Vincent
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
Antimicrobial agents and chemotherapy 2008;52(12):4251-7.
2008: Soriano Vincent; Geretti Anna María; Perno Carlo-Federico; Fätkenheuer Gerd; Pillay Deenan; Reynes Jacques; Tambussi Giuseppe; Calvez Vincent; Alcamí José; Rockstroh Juergen
Optimal use of maraviroc in clinical practice.
AIDS (London, England) 2008;22(17):2231-40.
2008: Lambert-Niclot Sidonie; Flandre Philippe; Malet Isabelle; Canestri Ana; Soulié Cathia; Tubiana Roland; Brunet Christel; Wirden Marc; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease.
The Journal of antimicrobial chemotherapy 2008;62(5):905-8.
2008: Soulié Cathia; Malet Isabelle; Lambert-Niclot Sidonie; Tubiana Roland; Thévenin Monique; Simon Anne; Murphy Robert; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients.
AIDS (London, England) 2008;22(16):2212-4.
2008: Amellal B; Murphy R; Maiga A; Brucker G; Katlama C; Calvez V; Marcelin A G
Stability of HIV RNA in plasma specimens stored at different temperatures.
HIV medicine 2008;9(9):790-3.
2008: Ait-Mohand H; Bonmarchand M; Guiguet M; Slama L; Marguet F; Behin A; Amellal B; Bennai Y; Peytavin G; Calvez V; Pialoux G; Murphy R; Katlama C
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
HIV medicine 2008;9(9):738-46.
2008: Duvivier Claudine; Ghosn Jade; Assoumou Lambert; Soulié Cathia; Peytavin Gilles; Calvez Vincent; Génin Michèle Algarté; Molina Jean-Michel; Bouchaud Olivier; Katlama Christine; Costagliola Dominique;
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
The Journal of antimicrobial chemotherapy 2008;62(4):797-808.
2008: Valantin M A; Lanoy E; Bentata M; Kalmykova O; Boutekadjirt A; Allavena C; Rozenbaum W; Peytavin G; Amellal B; Calvez V; Costagliola D; Katlama C;
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
HIV medicine 2008;9(8):625-35.
2008: Marcelin Anne-Genevieve; Masquelier Bernard; Descamps Diane; Izopet Jacques; Charpentier Charlotte; Alloui Chakib; Bouvier-Alias Magali; Signori-Schmuck Anne; Montes Brigitte; Chaix Marie-Laure; Amiel Corinne; Santos Georges Dos; Ruffault Annick; Barin Francis; Peytavin Gilles; Lavignon Marc; Flandre Philippe; Calvez Vincent
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2008;52(9):3237-43.
2008: Derache Anne; Maiga Almoustapha-Issiaka; Traore Ousmane; Akonde Alain; Cisse Mamadou; Jarrousse Bernard; Koita Victoria; Diarra Bah; Carcelain Guislaine; Barin Francis; Pizzocolo Cecilia; Pizarro Louis; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
The Journal of antimicrobial chemotherapy 2008;62(3):456-63.
2008: Descamps Diane; Assoumou Lambert; Masquelier Bernard; Marcelin Anne-Geneviève; Saidi Souhila; Tamalet Catherine; Cottalorda Jacqueline; Plantier Jean-Christophe; Montes Brigitte; Izopet Jacques; Peytavin Gilles; Yerly Sabine; Schneider Véronique; Delaugerre Constance; Ferré Virginie; Ruffault Annick; Pallier Coralie; Morand-Joubert Laurence; Chaix Marie-Laure; Calvez Vincent; Brun-Vézinet Françoise; Costagliola Dominique;
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
The Journal of antimicrobial chemotherapy 2008;62(3):451-5.
2008: Autran Brigitte; Murphy Robert L; Costagliola Dominique; Tubiana Roland; Clotet Bonaventura; Gatell Jose; Staszewski Schlomo; Wincker Norma; Assoumou Lambert; El-Habib Raphaelle; Calvez Vincent; Walker Bruce; Katlama Christine;
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).
AIDS (London, England) 2008;22(11):1313-22.
2008: Malet Isabelle; Soulie Cathia; Tchertanov Luba; Derache Anne; Amellal Bahia; Traore Ousmane; Simon Anne; Katlama Christine; Mouscadet Jean-François; Calvez Vincent; Marcelin Anne-Geneviève
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.
Journal of medical virology 2008;80(5):754-61.
2008: Ghosn Jade; De Montgolfier Ines; Cornélie Chantal; Dominguez Stéphanie; Pérot Claire; Peytavin Gilles; Marcelin Anne-Geneviève; Pauchard Michèle; Ouagari Zineb; Bonmarchand Manuela; Agher Rachid; Calvez Vincent; Bricaire François; Dommergues Marc; Katlama Christine; Tubiana Roland
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.
Antimicrobial agents and chemotherapy 2008;52(4):1542-4.
2008: Malet Isabelle; Delelis Olivier; Valantin Marc-Antoine; Montes Brigitte; Soulie Cathia; Wirden Marc; Tchertanov Luba; Peytavin Gilles; Reynes Jacques; Mouscadet Jean-François; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.
Antimicrobial agents and chemotherapy 2008;52(4):1351-8.
2008: Soulié C; Calvez V
[HIV tropism assays when first CCR5-antagonist becomes available]
Médecine et maladies infectieuses 2008;38 Suppl 1():S7-11.
2008: Lambert-Niclot Sidonie; Flandre Philippe; Canestri Ana; Peytavin Gilles; Blanc Christine; Agher Rachid; Soulié Cathia; Wirden Marc; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir.
Antimicrobial agents and chemotherapy 2008;52(2):491-6.
2008: Soulié C; Derache A; Aimé C; Marcelin A-G; Carcelain G; Simon A; Katlama C; Calvez V
Comparison of two genotypic algorithms to determine HIV-1 tropism.
HIV medicine 2008;9(1):1-5.
2007: Marcelin Anne-Geneviève; Jarrousse Bernard; Derache Anne; Ba Madina; Dakouo Marie-Léa; Doumbia Alioune; Haidara Ibrahima; Maïga Almoustapha; Carcelain Guislaine; Peytavin Gilles; Katlama Christine; Calvez Vincent
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.
AIDS (London, England) 2007;21(17):2341-3.
2007: Soulié Cathia; Marcelin Anne-Geneviève; Ghosn Jade; Amellal Bahia; Assoumou Lambert; Lambert Sidonie; Duvivier Claudine; Costagliola Dominique; Katlama Christine; Calvez Vincent
HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
AIDS (London, England) 2007;21(16):2243-5.
2007: Marcelin Anne-Geneviève; Motol Jérome; Guihot Amélie; Caumes Eric; Viard Jean-Paul; Dussaix Elisabeth; Cadranel Jacques; Frances Camille; Carcelain Guislaine; Calvez Vincent; Dupin Nicolas
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
The Journal of infectious diseases 2007;196(8):1163-6.
2007: Buffet Marc; Grange Philippe A; Gerhardt Philippe; Carlotti Agnès; Calvez Vincent; Bianchi Anne; Dupin Nicolas
Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry.
The Journal of investigative dermatology 2007;127(10):2345-50.
2007: Khonsari Roman H; Calvez Vincent
Concentric demyelination by self-organization: a new hypothesis for Baló's sclerosis.
Nature clinical practice. Neurology 2007;3(9):E1.
2007: King Martin S; Rode Richard; Cohen-Codar Isabelle; Calvez Vincent; Marcelin Anne-Geneviève; Hanna George J; Kempf Dale J
Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2007;51(9):3067-74.
2007: Canestri Ana; Cisse Mamadou; Marcelin Anne-Geneviève; Peytavin Gilles; Traore Emmanuel; Assoumou Lambert; Traore Ousmane; Koita Victoria; Diallo Fodie; Sangare Awa Thiero; Sidibé Mayrama Koita; Calvez Vincent; Sylla Aliou; Katlama Christine; Tubiana Roland
Experience of indinavir/ritonavir 400/100 mg twice-daily highly active antiretroviral therapy-containing regimen in HIV-1-infected patients in Bamako, Mali: the NOGOMA Study.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):477-9.
2007: Delaugerre Constance; Marcelin Anne-Genevieve; Soulié Cathia; Chaix Marie-Laure; Katlama Christine; Girard Pierre-Marie; Calvez Vincent; Morand-Joubert Laurence
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey.
AIDS (London, England) 2007;21(10):1365-7.
2007: Amellal B; Allavena C; André-Garnier E; Ferré V; Valantin M A; Delfraissy J F; Lafeuillade A; Bonmarchand M; Calvez V; Raffi F
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study).
The Journal of infection 2007;54(6):603-8.
2007: Malet Isabelle; Wirden Marc; Derache Anne; Simon Anne; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
AIDS (London, England) 2007;21(7):871-3.
2007: Malet Isabelle; Roquebert Bénédicte; Dalban Cécile; Wirden Marc; Amellal Bahia; Agher Rachid; Simon Anne; Katlama Christine; Costagliola Dominique; Calvez Vincent; Marcelin Anne-Geneviève
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
The Journal of infection 2007;54(4):367-74.
2007: Roquebert Bénédicte; Wirden Marc; Simon Anne; Deval Jérome; Katlama Christine; Calvez Vincent; Marcelin Anne-Geneviève
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
Journal of medical virology 2007;79(3):207-11.
2007: Flandre Philippe; Chappey Colombe; Marcelin Anne Genevieve; Ryan Kirk; Maa Jen-Fue; Bates Mike; Seekins Daniel; Bernard Marie Charlotte; Calvez Vincent; Molina Jean Michel
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
The Journal of infectious diseases 2007;195(3):392-8.
2007: Dominguez Stephanie; Ghosn Jade; Peytavin Gilles; Izzedine Hassan; Wirden Marc; Ktorza Nadine; Miller Michael; Aubron-Olivier Camille; Trylesinski Aldo; Calvez Vincent; Deray Gilbert; Katlama Christine
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.
Journal of medical virology 2007;79(2):105-10.
2007: Chêne Geneviève; Amellal Bahia; Pédrono Gaëlle; Gourlain Karine; Rancinan Corinne; Journot Valérie; Cotte Laurent; Palmer Pierre; Castro Nathalie De; Calvez Vincent; Molina Jean-Michel;
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
AIDS research and human retroviruses 2007;23(1):54-61.
2007: Derache Anne; Traore Ousmane; Koita Victoria; Sylla Aliou; Tubiana Roland; Simon Anne; Canestri Ana; Carcelain Guislaine; Katlama Christine; Calvez Vincent; Cisse Mamadou; Marcelin Anne-Geneviève
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Antiviral therapy 2007;12(1):123-9.
2007: Marcelin Anne-Genevieve; Flandre Philippe; de Mendoza Carmen; Roquebert Benedicte; Peytavin Gilles; Valer Luisa; Wirden Marc; Abbas Sarah; Katlama Christine; Soriano Vincent; Calvez Vincent
Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
Antiviral therapy 2007;12(2):247-52.
2007: Khonsari Roman H; Calvez Vincent
The origins of concentric demyelination: self-organization in the human brain.
PloS one 2007;2(1):e150.
2007: Marcelin A G; Calvez V; Dussaix E
KSHV after an organ transplant: should we screen?
Current topics in microbiology and immunology 2007;312():245-62.
2006: Wirden Marc; Roquebert Bénédicte; Derache Anne; Simon Anne; Duvivier Claudine; Ghosn Jade; Dominguez Stephanie; Boutonnet Véronique; Ait-Arkoub Zaina; Katlama Christine; Calvez Vincent; Marcelin Anne-Genevieve
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2006;50(7):2553-6.
2006: Marcelin Anne-Geneviève; Calvez Vincent
[HIV drug resistance]
La Revue du praticien 2006;56(9):978-86.
2006: Marcelin Anne-Geneviève; Chazallon Corine; Gérard Laurence; Saïdi Yacine; Aboulker Jean-Pierre; Girard Pierre-Marie; Calvez Vincent; Piketty Christophe
External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):127-8.
2006: Descamps Diane; Delaugerre Constance; Masquelier Bernard; Ruffault Annick; Marcelin Anne-Geneviève; Izopet Jacques; Chaix Marie-Laure; Calvez Vincent; Brun-Vézinet Françoise; Costagliola Dominique
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
Journal of medical virology 2006;78(2):153-60.
2006: Roquebert Bénédicte; Malet Isabelle; Wirden Marc; Tubiana Roland; Valantin Marc-Antoine; Simon Anne; Katlama Christine; Peytavin Gilles; Calvez Vincent; Marcelin Anne-Geneviève
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.
AIDS (London, England) 2006;20(2):287-9.
2006: Vora Samir; Marcelin Anne-Geneviève; Günthard Huldrych F; Flandre Philippe; Hirsch Hans H; Masquelier Bernard; Zinkernagel Annelies; Peytavin Gilles; Calvez Vincent; Perrin Luc; Yerly Sabine;
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.
AIDS (London, England) 2006;20(1):35-40.
2006: Benhamou Yves; Thibault Vincent; Vig Pamela; Calvez Vincent; Marcelin Anne-Genevieve; Fievet Marie-Hélène; Currie Graeme; Chang Chuy G; Biao Lu; Xiong Shelly; Brosgart Carol; Poynard Thierry
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Journal of hepatology 2006;44(1):62-7.
2006: Marcelin Anne-Genevieve; Flandre Philippe; Furco Andre; Wirden Marc; Molina Jean-Michel; Calvez Vincent;
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.
Antiviral therapy 2006;11(6):693-9.
2006: Canestri Ana; Ghosn Jade; Wirden Marc; Marguet Françoise; Ktorza Nadine; Boubezari Imane; Dominguez Stéphanie; Bossi Philippe; Caumes Eric; Calvez Vincent; Katlama Christine
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance.
Antiviral therapy 2006;11(5):561-6.
2006: Piketty Christophe; Gérard Laurence; Chazallon Corine; Marcelin Anne-Geneviève; Clavel François; Taburet Anne-Marie; Calvez Vincent; Madelaine-Chambrin Isabelle; Molina Jean-Michel; Aboulker Jean-Pierre; Girard Pierre-Marie;
Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.
Antiviral therapy 2006;11(2):213-21.
2005: Delaugerre Constance; Peytavin Gilles; Dominguez Stephanie; Marcelin Anne-Genevieve; Duvivier Claudine; Gourlain Karine; Amellal Bahia; Legrand Mayeule; Raffi François; Costagliola Dominique; Katlama Christine; Calvez Vincent
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Journal of medical virology 2005;77(3):345-50.
2005: Marcelin Anne-Genevieve; Flandre Philippe; Peytavin Gilles; Calvez Vincent
Predictors of virologic response to ritonavir-boosted protease inhibitors.
AIDS reviews 2005;7(4):225-32.
2005: Ghosn Jade; Wirden Marc; Ktorza Nadine; Peytavin Gilles; Aït-Mohand Hocine; Schneider Luminita; Dominguez Stéphanie; Bricaire François; Calvez Vincent; Costagliola Dominique; Katlama Christine
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.
AIDS (London, England) 2005;19(15):1643-7.
2005: Masquelier Bernard; Costagliola Dominique; Schmuck Anne; Cottalorda Jacqueline; Schneider Véronique; Izopet Jacques; Calvez Vincent; Descamps Diane; Poggi Cécile; Brun-Vézinet Françoise;
Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
Journal of medical virology 2005;76(4):441-6.
2005: Montani David; Marcelin Anne-Genevieve; Sitbon Olivier; Calvez Vincent; Simonneau Gérald; Humbert Marc
Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France.
AIDS (London, England) 2005;19(11):1239-40.
2005: Martinez Valérie; Marcelin Anne-Geneviève; Morini Jean-Pierre; Deleuze Jean; Krivine Anne; Gorin Isabelle; Yerly Sabine; Perrin Luc; Peytavin Gilles; Calvez Vincent; Dupin Nicolas
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen.
AIDS (London, England) 2005;19(10):1065-9.
2005: Tubiana Roland; Carcelain Guislaine; Vray Muriel; Gourlain Karine; Dalban Cécile; Chermak Aziza; Rabian Claire; Vittecoq Daniel; Simon Anne; Bouvet Elisabeth; El Habib Raphaelle; Costagliola Dominique; Calvez Vincent; Autran Brigitte; Katlama Christine;
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).
Vaccine 2005;23(34):4292-301.
2005: Wirden Marc; Marcelin Anne Genevieve; Simon Anne; Kirstetter Myriam; Tubiana Roland; Valantin Marc-Antoine; Paris Luc; Bonmarchand Manuela; Conan Francoise; Kalkias Laurence; Katlama Christine; Calvez Vincent
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.
Journal of medical virology 2005;76(3):297-301.
2005: Grange Philippe A; Marcelin Anne-Geneviève; Calvez Vincent; Chauvel Caroline; Escande Jean-Paul; Dupin Nicolas
Salivary lactoferrin is recognized by the human herpesvirus-8.
The Journal of investigative dermatology 2005;124(6):1249-58.
2005: Marcelin Anne-Geneviève; Flandre Philippe; Pavie Juliette; Schmidely Nathalie; Wirden Marc; Lada Olivier; Chiche Dan; Molina Jean-Michel; Calvez Vincent;
Clinically relevant genotype interpretation of resistance to didanosine.
Antimicrobial agents and chemotherapy 2005;49(5):1739-44.
2005: Marcelin Anne-Geneviève; Cohen-Codar Isabelle; King Martin S; Colson Philippe; Guillevic Emmanuel; Descamps Diane; Lamotte Claire; Schneider Véronique; Ritter Jacques; Segondy Michel; Peigue-Lafeuille Hélène; Morand-Joubert Laurence; Schmuck Anne; Ruffault Annick; Palmer Pierre; Chaix Marie-Laure; Mackiewicz Vincent; Brodard Véronique; Izopet Jacques; Cottalorda Jacqueline; Kohli Evelyne; Chauvin Jean-Pierre; Kempf Dale J; Peytavin Gilles; Calvez Vincent
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2005;49(5):1720-6.
2005: Buffet Marc; Schwarzinger Michaël; Amellal Bahia; Gourlain Karine; Bui Patrick; Prévot Marianne; Deleuze Jean; Morini Jean-Pierre; Gorin Isabelle; Calvez Vincent; Dupin Nicolas
Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):60-4.
2005: Wirden Marc; Malet Isabelle; Derache Anne; Marcelin Anne Genevieve; Roquebert Benedicte; Simon Anne; Kirstetter Myriam; Joubert Laurence Morand; Katlama Christine; Calvez Vincent
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution.
AIDS (London, England) 2005;19(6):630-2.
2005: Molina Jean-Michel; Marcelin Anne-Geneviève; Pavie Juliette; Heripret Laurence; De Boever Corinne Merle; Troccaz Martine; Leleu Ghislaine; Calvez Vincent;
Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.
The Journal of infectious diseases 2005;191(6):840-7.
2005: Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin A G; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
AIDS (London, England) 2005;19(1):25-33.
2005: Flandre Philippe; Marcelin Anne-Geneviève; Pavie Juliette; Shmidely Nathalie; Wirden Marc; Lada Olivier; Bernard Marie-Charlotte; Molina Jean-Michel; Calvez Vincent
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.
Antiviral therapy 2005;10(4):479-87.
2004: Marcelin Anne-Geneviève; Dalban Cécile; Peytavin Gilles; Lamotte Claire; Agher Rachid; Delaugerre Constance; Wirden Marc; Conan Françoise; Dantin Sylvie; Katlama Christine; Costagliola Dominique; Calvez Vincent
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2004;48(12):4687-92.
2004: Gabarre Jean; Marcelin Anne-Geneviève; Azar Nabih; Choquet Sylvain; Lévy Vincent; Lévy Yves; Tubiana Roland; Charlotte Frédéric; Norol Françoise; Calvez Vincent; Spina Michele; Vernant Jean-Paul; Autran Brigitte; Leblond Véronique
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Haematologica 2004;89(9):1100-8.
2004: Bossi P; Peytavin G; Ait-Mohand H; Delaugerre C; Ktorza N; Paris L; Bonmarchand M; Cacace R; David D-J; Simon A; Lamotte C; Marcelin A-G; Calvez V; Bricaire F; Costagliola D; Katlama C
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
HIV medicine 2004;5(5):352-9.
2004: Marcelin Anne-Geneviève; Affolabi Dissou; Lamotte Claire; Mohand Hocine Ait; Delaugerre Constance; Wirden Marc; Voujon Delphine; Bossi Philippe; Ktorza Nadine; Bricaire François; Costagliola Dominique; Katlama Christine; Peytavin Gilles; Calvez Vincent
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients.
Journal of medical virology 2004;74(1):16-20.
2004: Brun-Vézinet Françoise; Costagliola Dominique; Khaled Mounir Ait; Calvez Vincent; Clavel François; Clotet Bonaventura; Haubrich Richard; Kempf Dale; King Marty; Kuritzkes Daniel; Lanier Randall; Miller Michael; Miller Veronica; Phillips Andrews; Pillay Deenan; Schapiro Jonathan; Scott Janna; Shafer Robert; Zazzi Maurizio; Zolopa Andrew; DeGruttola Victor
Clinically validated genotype analysis: guiding principles and statistical concerns.
Antiviral therapy 2004;9(4):465-78.
2004: Marcelin Anne-Geneviève; Gorin Isabelle; Morand Patrice; Ait-Arkoub Zaina; Deleuze Jean; Morini Jean-Pierre; Calvez Vincent; Dupin Nicolas
Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
AIDS research and human retroviruses 2004;20(7):704-8.
2004: Wirden Marc; Marcelin Anne Geneviève; Tubiana Roland; Valantin Marc Antoine; Ghosn Jade; Duvivier Claudine; Dominguez Stéphanie; Paris Luc; Agher Rachid; Peytavin Gilles; Katlama Christine; Calvez Vincent
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):876-8.
2004: Piketty Christophe; Gérard Laurence; Chazallon Corine; Calvez Vincent; Clavel François; Taburet Anne-Marie; Girard Pierre-Marie; Aboulker Jean-Pierre;
Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures.
AIDS (London, England) 2004;18(10):1469-71.
2004: Marcelin Anne-Geneviève; Reynes Jacques; Yerly Sabine; Ktorza Nadine; Segondy Michel; Piot Jean-Claude; Delfraissy Jean-François; Kaiser Laurent; Perrin Luc; Katlama Christine; Calvez Vincent
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.
AIDS (London, England) 2004;18(9):1340-2.
2004: Katlama Christine; Ghosn Jade; Tubiana Roland; Wirden Marc; Valantin Marc-Antoine; Harmenberg Johan; Mårdh Göran; Oberg Bo; Calvez Vincent
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.
AIDS (London, England) 2004;18(9):1299-304.
2004: Delaugerre Constance; Morand-Joubert Laurence; Chaix Marie-Laure; Picard Odile; Marcelin Anne-Genevieve; Schneider Veronique; Krivine Anne; Compagnucci Alexandra; Katlama Christine; Girard Pierre-Marie; Calvez Vincent
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
Antiviral therapy 2004;9(3):415-21.
2004: Taburet Anne-Marie; Piketty Christophe; Chazallon Corine; Vincent Isabelle; Gérard Laurence; Calvez Vincent; Clavel Francois; Aboulker Jean-Pierre; Girard Pierre-Marie
Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2004;48(6):2091-6.
2004: Marcelin Anne-Geneviève; Roque-Afonso Anne-Marie; Hurtova Monika; Dupin Nicolas; Tulliez Micheline; Sebagh Mylène; Arkoub Zaïna Ait; Guettier Catherine; Samuel Didier; Calvez Vincent; Dussaix Elisabeth
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(2):295-300.
2004: Wirden Marc; Delaugerre Constance; Marcelin Anne Genevieve; Ktorza Nadine; Ait Mohand Hocine; Dominguez Stephanie; Schneider Luminita; Ghosn Jade; Pauchard Michele; Costagliola Dominique; Katlama Christine; Calvez Vincent
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.
Antimicrobial agents and chemotherapy 2004;48(2):644-7.
2004: Katlama Christine; Dominguez Stéphanie; Gourlain Karine; Duvivier Claudine; Delaugerre Constance; Legrand Mayeule; Tubiana Roland; Reynes Jacques; Molina Jean-Michel; Peytavin Gilles; Calvez Vincent; Costagliola Dominique
Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097).
AIDS (London, England) 2004;18(2):217-26.
2004: Marcelin Anne-Geneviève; Delaugerre Constance; Wirden Marc; Viegas Pedro; Simon Anne; Katlama Christine; Calvez Vincent
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
Journal of medical virology 2004;72(1):162-5.
2003: Duvivier Claudine; Myrto Astriti; Marcelin Anne-Geneviève; Ghosn Jade; Ait-Mohand Hocine; Schneider Luminita; Agher Rachid; Bricaire François; Costagliola Dominique; Calvez Vincent; Peytavin Gilles; Katlama Christine
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Antiviral therapy 2003;8(6):603-9.
2003: Perrot Serge; Calvez Vincent; Escande Jean-Paul; Dupin Nicolas; Marcelin Anne-Geneviève
Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;28(2):165-8.
2003: Marcelin Anne-Geneviève; Aaron Laurent; Mateus Christine; Gyan Emmanuel; Gorin Isabelle; Viard Jean-Paul; Calvez Vincent; Dupin Nicolas
Rituximab therapy for HIV-associated Castleman disease.
Blood 2003;102(8):2786-8.
2003: Brun-Vézinet Françoise; Descamps Diane; Ruffault Annick; Masquelier Bernard; Calvez Vincent; Peytavin Gilles; Telles Fabienne; Morand-Joubert Laurence; Meynard Jean-Luc; Vray Muriel; Costagliola Dominique;
Clinically relevant interpretation of genotype for resistance to abacavir.
AIDS (London, England) 2003;17(12):1795-802.
2003: Gourlain K; Amellal B; Ait Arkoub Z; Dupin N; Katlama C; Calvez V
Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.
HIV medicine 2003;4(3):287-92.
2003: Delaugerre Constance; Gourlain Karine; Tubiana Roland; Carcelain Guislaine; Marcelin Anne-Geneviève; Chouquet Cécile; Mouroux Mireille; Duvivier Claudine; Autran Brigitte; Costagliola Dominique; Katlama Christine; Calvez Vincent
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Antiviral therapy 2003;8(3):233-7.
2003: Ait-Arkoub Zaïna; Robert-Visse Catherine; Calvez Vincent; Costagliola Dominique; Autran Brigitte; Candotti Daniel; Agut Henri;
No influence of human herpesvirus 8 infection on the progression of HIV-1 infection in initially asymptomatic patients.
AIDS (London, England) 2003;17(9):1394-6.
2003: Wirden Marc; Simon Anne; Schneider Luminita; Tubiana Roland; Paris Luc; Marcelin Anne Genevieve; Delaugerre Constance; Legrand Mayeule; Herson Serge; Peytavin Gilles; Katlama Christine; Calvez Vincent
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs.
Journal of clinical microbiology 2003;41(6):2713-5.
2003: Kousignian I; Autran B; Chouquet C; Calvez V; Gomard E; Katlama C; Rivière Y; Costagliola D;
Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
Statistics in medicine 2003;22(10):1675-90.
2003: Bossi Philippe; Peytavin Gilles; Lamotte Claire; Calvez Vincent; Bricaire François; Costagliola Dominique; Katlama Christine
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors.
AIDS (London, England) 2003;17(7):1108-10.
2003: Marcelin Anne-Geneviève; Lamotte Claire; Delaugerre Constance; Ktorza Nadine; Ait Mohand Hocine; Cacace Raquel; Bonmarchand Manuela; Wirden Marc; Simon Anne; Bossi Philippe; Bricaire François; Costagliola Dominique; Katlama Christine; Peytavin Gilles; Calvez Vincent;
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2003;47(2):594-600.
2003: Ghosn Jade; Lamotte Claire; Ait-Mohand Hocine; Wirden Marc; Agher Rachid; Schneider Luminita; Bricaire François; Duvivier Claudine; Calvez Vincent; Peytavin Gilles; Katlama Christine
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.
AIDS (London, England) 2003;17(2):209-14.
2003: Bossi P; Legrand O; Faussat A-M; Legrand M; Bricaire F; Marie J-P; Agut H; Diquet B; Katlama C; Huraux J-M; Calvez V
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors.
HIV medicine 2003;4(1):67-71.
2002: Dupin Nicolas; Buffet Marc; Marcelin Anne-Geneviève; Lamotte Claire; Gorin Isabelle; Ait-Arkoub Zaina; Tréluyer Jean-Marc; Bui Patrick; Calvez Vincent; Peytavin Gilles
HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophy.
AIDS (London, England) 2002;16(18):2419-24.
2002: Chouquet Cécile; Autran Brigitte; Gomard Elisabeth; Bouley Jean-Marc; Calvez Vincent; Katlama Christine; Costagliola Dominique; Rivière Yves;
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.
AIDS (London, England) 2002;16(18):2399-407.
2002: Gill Jasjit; Bourboulia Dimitra; Wilkinson John; Hayes Peter; Cope Alethea; Marcelin Anne-Genevieve; Calvez Vincent; Gotch Frances; Boshoff Christopher; Gazzard Brian
Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
Journal of acquired immune deficiency syndromes (1999) 2002;31(4):384-90.
2002: Katlama Christine; Carcelain Guislaine; Duvivier Claudine; Chouquet Cécile; Tubiana Roland; De Sa Marcio; Zagury Liliane; Calvez Vincent; Autran Brigitte; Costagliola D;
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
AIDS (London, England) 2002;16(15):2027-34.
2002: Tattevin Pierre; Davi Frédéric; Merle-Béral Hélène; Calvez Vincent; Hermine Olivier; Papo Thomas
Chronic lymphocytic lymphoma and multiple myeloma in a patient infected with human herpesvirus 8 (HHV-8).
American journal of hematology 2002;71(2):138-9.
2002: Marcelin Anne-Geneviève; Grandadam Marc; Flandre Philippe; Nicand Elisabeth; Milliancourt Catherine; Koeck Jean-Louis; Philippon Michel; Teyssou Remy; Agut Henri; Dupin Nicolas; Calvez Vincent
Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti.
Journal of medical virology 2002;68(2):164-7.
2002: Calvez Vincent; Costagliola Dominique; Descamps Diane; Yvon Anne; Collin Gilles; Cécile Agnès; Delaugerre Constance; Damond Florence; Marcelin Anne-Geneviève; Matheron Sophie; Simon Anne; Valantin Marc-Antoine; Katlama Christine; Brun-Vézinet Françoise
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Antiviral therapy 2002;7(3):211-8.
2002: Emond Jean-Philippe; Marcelin Anne-Geneviève; Dorent Richard; Milliancourt Catherine; Dupin Nicolas; Frances Camille; Agut Henri; Gandjbakhch Iradj; Calvez Vincent
Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients.
Journal of clinical microbiology 2002;40(6):2217-9.
2002: Delaugerre Constance; Marcelin Anne-Geneviève; Thibault Vincent; Peytavin Gilles; Bombled Tony; Bochet Marie-Valérie; Katlama Christine; Benhamou Yves; Calvez Vincent
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.
Antimicrobial agents and chemotherapy 2002;46(5):1586-8.
2002: Flandre Philippe; Raffi François; Descamps Diane; Calvez Vincent; Peytavin Gilles; Meiffredy Vincent; Harel Marine; Hazebrouck Sylvie; Pialoux Gilles; Aboulker Jean-Pierre; Brun Vezinet Françoise
Final analysis of the Trilège induction-maintenance trial: results at 18 months.
AIDS (London, England) 2002;16(4):561-8.
2002: Wilkinson John; Cope Alethea; Gill Jas; Bourboulia Dimitra; Hayes Peter; Imami Nesrina; Kubo Toru; Marcelin Anne; Calvez Vincent; Weiss Robin; Gazzard Brian; Boshoff Chris; Gotch Frances
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
Journal of virology 2002;76(6):2634-40.
2002: Thibault Vincent; Delaugerre Constance; Calvez Vincent; Costagliola Dominique; Tubiana Roland; Katlama Christine
Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial.
Hepatology (Baltimore, Md.) 2002;35(1):238-9.
2001: Marcelin A G; Milliancourt C; Dupin N; Wirden M; Huraux J M; Agut H; Calvez V
Effects of cyclosporine and hydrocortisone on Kaposi's sarcoma-associated herpesvirus genome replication and cell apoptosis induction.
Transplantation 2001;72(10):1700-3.
2001: Delaugerre C; Valantin M A; Mouroux M; Bonmarchand M; Carcelain G; Duvivier C; Tubiana R; Simon A; Bricaire F; Agut H; Autran B; Katlama C; Calvez V
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.
AIDS (London, England) 2001;15(16):2189-91.
2001: Delaugerre C; Rohban R; Simon A; Mouroux M; Tricot C; Agher R; Huraux J M; Katlama C; Calvez V
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
Journal of medical virology 2001;65(3):445-8.
2001: Milliancourt C; Barete S; Marcelin A G; Mouquet C; Dupin N; Francès C; Agut H; Bitker M O; Calvez V
Human herpesvirus-8 seroconversions after renal transplantation.
Transplantation 2001;72(7):1319-20.
2001: Mouroux M; Descamps D; Izopet J; Yvon A; Delaugerre C; Matheron S; Coutellier A; Valantin M A; Bonmarchand M; Agut H; Massip P; Costagliola D; Katlama C; Brun-Vezinet F; Calvez V
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Antiviral therapy 2001;6(3):179-83.
2001: Descamps D; Calvez V; Izopet J; Buffet-Janvresse C; Schmuck A; Colson P; Ruffault A; Maillard A; Masquelier B; Cottalorda J; Harzic M; Brun-Vézinet F; Costagliola D;
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001;15(14):1777-82.
2001: Singh M K; Janvier G; Calvez V; Coulaud P; Rivière Y
A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
AIDS research and human retroviruses 2001;17(13):1265-71.
2001: Benhamou Y; Bochet M; Thibault V; Calvez V; Fievet M H; Vig P; Gibbs C S; Brosgart C; Fry J; Namini H; Katlama C; Poynard T
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Lancet 2001;358(9283):718-23.
2001: Yvon-Groussin A; Mugnier P; Bertin P; Grandadam M; Agut H; Huraux J M; Calvez V
Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure.
Journal of virology 2001;75(15):7184-7.
2001: Masquelier B; Race E; Tamalet C; Descamps D; Izopet J; Buffet-Janvresse C; Ruffault A; Mohammed A S; Cottalorda J; Schmuck A; Calvez V; Dam E; Fleury H; Brun-Vézinet F;
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors.
Antimicrobial agents and chemotherapy 2001;45(6):1836-42.
2001: Delaugerre C; Mouroux M; Yvon-Groussin A; Simon A; Angleraud F; Huraux J M; Agut H; Katlama C; Calvez V
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
Antimicrobial agents and chemotherapy 2001;45(3):946-8.
2001: Katlama C; Pellegrin J L; Lacoste D; Aquilina C; Raffi F; Pialoux G; Vittecoq D; Raguin G; Lantz O; Mouroux M; Calvez V; Trylesinski A; Montestruc F; Dohin E; Goehrs J M; Delfraissy J F
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.
HIV medicine 2001;2(1):20-6.
2001: Stankoff B; Tourbah A; Suarez S; Turell E; Stievenart J L; Payan C; Coutellier A; Herson S; Baril L; Bricaire F; Calvez V; Cabanis E A; Lacomblez L; Lubetzki C
Clinical and spectroscopic improvement in HIV-associated cognitive impairment.
Neurology 2001;56(1):112-5.
2001: Carcelain G; Tubiana R; Samri A; Calvez V; Delaugerre C; Agut H; Katlama C; Autran B
Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
Journal of virology 2001;75(1):234-41.
2000: Combadère B; Blanc C; Li T; Carcelain G; Delaugerre C; Calvez V; Tubiana R; Debré P; Katlama C; Autran B
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle.
European journal of immunology 2000;30(12):3598-603.
2000: Burgard M; Izopet J; Dumon B; Tamalet C; Descamps D; Ruffault A; Vabret A; Bargues G; Mouroux M; Pellegrin I; Ivanoff S; Guisthau O; Calvez V; Seigneurin J M; Rouzioux C
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
AIDS research and human retroviruses 2000;16(18):1939-47.
2000: Barete S; Calvez V; Mouquet C; Barrou B; Kreis H; Dantal J; Dorent R; Durand F; Dimitrov Y; Dupin N; Marcelin A G; Piette J C; Bitker M O; Francès C
Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients.
Archives of dermatology 2000;136(12):1452-8.
2000: Samri A; Haas G; Duntze J; Bouley J M; Calvez V; Katlama C; Autran B
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.
Journal of virology 2000;74(19):9306-12.
2000: Mollet L; Li T S; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1692-704.
2000: Mouroux M; Yvon-Groussin A; Peytavin G; Delaugerre C; Legrand M; Bossi P; Do B; Trylesinski A; Diquet B; Dohin E; Delfraissy J F; Katlama C; Calvez V
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.
Journal of clinical microbiology 2000;38(7):2726-30.
2000: Mouroux M; Izopet J; Descamps D; Delaugerre C; Yvon-Groussin A; Angleraud F; Coutellier A; Bonmarchand M; Valantin M A; Matheron S; Agut H; Katlama C; Brun-Vezinet F; Calvez V
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T]
Pathologie-biologie 2000;48(5):508-12.
2000: Dupin N; Calvez V
[HHV-8/KSHV. I - epidemiological and molecular aspects]
Annales de dermatologie et de vénéréologie 2000;127(5):528-31.
2000: Francès C; Mouquet C; Marcelin A G; Barete S; Agher R; Charron D; Benalia H; Dupin N; Piette J C; Bitker M O; Calvez V
Outcome of kidney transplant recipients with previous human herpesvirus-8 infection.
Transplantation 2000;69(9):1776-9.
2000: Dupin N; Marcelin A G; Caumes E; Barete S; Arkoub Z A; Bossi P; Agher R; Calvez V
Relationship between Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus and AIDS dementia complex.
AIDS (London, England) 2000;14(3):333-5.
2000: Descamps D; Flandre P; Calvez V; Peytavin G; Meiffredy V; Collin G; Delaugerre C; Robert-Delmas S; Bazin B; Aboulker J P; Pialoux G; Raffi F; Brun-Vézinet F
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
JAMA : the journal of the American Medical Association 2000;283(2):205-11.
1999: Calvez V; Barete S; Dupin N
[Human herpesvirus 8 (HHV-8)]
La Revue du praticien 1999;49(20):2232-6.
1999: Stankoff B; Calvez V; Suarez S; Bossi P; Rosenblum O; Conquy L; Turell E; Dubard T; Coutellier A; Baril L; Bricaire F; Lacomblez L; Lubetzki C
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(6):669-75.
1999: Bossi P; Mouroux M; Yvon A; Bricaire F; Agut H; Huraux J M; Katlama C; Calvez V
Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.
Journal of clinical microbiology 1999;37(9):2910-2.
1999: Dupin N; Marcelin A G; Calvez V; Andr C
Absence of a link between human herpesvirus 8 and pemphigus.
The British journal of dermatology 1999;141(1):159-60.
1999: Mouroux M; Bossi P; Yvon-Groussin A; Delaugerre C; Valantin M A; Tubiana R; Coutellier A; Bonmarchand M; Bricaire F; Katlama C; Agut H; Huraux J M; Calvez V
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor]
Pathologie-biologie 1999;47(5):549-52.
1999: Grassi F; Hosmalin A; McIlroy D; Calvez V; Debré P; Autran B
Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.
AIDS (London, England) 1999;13(7):759-66.
1999: Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard J P; Huraux J M; Escande J P
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
The British journal of dermatology 1999;140(5):875-81.
1999: Renaud M; Katlama C; Mallet A; Calvez V; Carcelain G; Tubiana R; Jouan M; Caumes E; Agut H; Bricaire F; Debré P; Autran B
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.
AIDS (London, England) 1999;13(6):669-76.
1999: Francès C; Mouquet C; Calvez V
Human herpesvirus 8 and renal transplantation.
The New England journal of medicine 1999;340(13):1045; author reply 1046.
1999: Autran B; Carcelaint G; Li T S; Gorochov G; Blanc C; Renaud M; Durali M; Mathez D; Calvez V; Leibowitch J; Katlama C; Debré P
Restoration of the immune system with anti-retroviral therapy.
Immunology letters 1999;66(1-3):207-11.
1999: Papo T; Soubrier M; Marcelin A G; Calvez V; Wechsler B; Huraux J M; Piette J C; Cacoub P
Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome.
British journal of haematology 1999;104(4):932-3.
1999: Tubiana R; Carcelain G; Mohand H A; Li T S; Renaud M; Blanc C; Calvez V; Debré P; Agut H; Katlama C; Autran B; Bricaire F
[Immunologic reconstruction after antiretroviral treatment]
Presse médicale (Paris, France : 1983) 1999;28(8):424-8.
1999: Carcelain G; Li T S; Renaud M; Blanc C; Tubiana R; Calvez V; Leibowitch J; Debré P; Agut H; Katlama C; Autran B
[Antiretroviral therapy and immune reconstitution]
Journal de la Société de biologie 1999;193(1):5-10.
1998: Stankoff B; Suarez S; Rosemblum O; Conquy L; Turell E; Bricaire F; Coutellier A; Calvez V; Lacomblez L; Tourbah A; Lubetzki C
[Cognitive disorders in AIDS: clinical, virological and neuroradiological features]
Revue neurologique 1998;154(12):843-9.
1998: Calvez V; Bossi P
[HHV-8 related diseases]
Presse médicale (Paris, France : 1983) 1998;27 Suppl 5():16.
1998: Marcelin A G; Apetrei C; Dupin N; Bossi P; Descamps D; Simon F; Calvez V
Parenteral transmission of Kaposi's sarcoma-associated herpesvirus.
AIDS (London, England) 1998;12(17):2351.
1998: Bossi P; Yvon A; Mouroux M; Huraux J M; Agut H; Calvez V
Mutations in the human immunodeficiency virus type 1 reverse transcriptase gene observed in stavudine and didanosine strains obtained by in vitro passages.
Research in virology 1998;149(6):355-61.
1998: Katlama C; Valantin M A; Matheron S; Coutellier A; Calvez V; Descamps D; Longuet C; Bonmarchand M; Tubiana R; De Sa M; Lancar R; Agut H; Brun-Vezinet F; Costagliola D
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
Annals of internal medicine 1998;129(7):525-31.
1998: Descamps D; Calvez V; Collin G; Cécille A; Apetrei C; Damond F; Katlama C; Matheron S; Huraux J M; Brun-Vézinet F
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.
Journal of clinical microbiology 1998;36(7):2143-5.
1998: Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
[Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis]
Pathologie-biologie 1998;46(6):423-5.
1998: Li T S; Tubiana R; Katlama C; Calvez V; Ait Mohand H; Autran B
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.
Lancet 1998;351(9117):1682-6.
1998: Dupin N; Marcelin A G; Gorin I; Bossi P; Franck N; Weill B; Huraux J M; Escande J P; Calvez V
Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases.
Archives of dermatology 1998;134(6):700-2.
1998: Bossi P; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(5):1072-3.
1998: Karmochkine M; Parizot C; Calvez V; Coutellier A; Herson S; Debré P; Gorochov G
Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(5):419-23.
1998: Mollet L; Sadat-Sowti B; Duntze J; Leblond V; Bergeron F; Calvez V; Katlama C; Debré P; Autran B
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
International immunology 1998;10(3):311-23.
1998: Mansour G; Charlotte F; Calvez V; Davi F; Merle-Béral H
AIDS-related primary lymphoma of the pleural cavity. A case report.
Acta cytologica 1998;42(2):371-3.
1998: Marcelin A G; Dupin N; Bossi P; Calvez V
Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France.
AIDS (London, England) 1998;12(5):539-40.
1997: Marcelin A G; Dupin N; Bouscary D; Bossi P; Cacoub P; Ravaud P; Calvez V
HHV-8 and multiple myeloma in France.
Lancet 1997;350(9085):1144.
1997: Dupin N; Krivine A; Calvez V; Gorin I; Franck N; Escande J P
No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
AIDS (London, England) 1997;11(11):1400-1.
1997: Agut H; Calvez V; Fillet A M; Huraux J M
[The discovery of three novel human viruses, human herpesviruses 6, 7, and 8]
Bulletin de l'Académie nationale de médecine 1997;181(6):1009-22.
1997: Huraux J M; Moutouh L; Calvez V; Dupin N
[The 8th human herpesvirus]
Presse médicale (Paris, France : 1983) 1997;26(22):1058-62.
1997: Dupin N; Franck N; Calvez V; Gorin I; Grandadam M; Huraux J M; Leibowitch M; Agut H; Escande J P
Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin.
The British journal of dermatology 1997;136(6):827-30.
1997: Agut H; Fillet A M; Calvez V
[What is a virus?]
La Revue du praticien 1997;47(6):602-7.
1996: Dupin N; Perrot S; Calvez V; Gorin I; Grandadam M; Agut H; Escande J P; Menkès C J
Detection of HHV-8 in Sjögren's syndrome.
The American journal of medicine 1996;101(6):657-8.
1995: Dupin N; Grandadam M; Calvez V; Gorin I; Aubin J T; Havard S; Lamy F; Leibowitch M; Huraux J M; Escande J P
Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.
Lancet 1995;345(8952):761-2.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vincent Calvez

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vincent Calvez (preview)

All Publications